AC BioScience SA Switzerland

Andreas Schlaepfer
CEO 

Acino International Switzerland

Website:
www.acino.swiss
Dr Timo Taghizadeh
Director Outlicensing 

Alvogen Switzerland

Alvogen is a global, privately owned pharmaceutical company focused on developing, manufacturing and selling generic, brand, OTC and biosimilar products around the world.

A unique portfolio of high-quality and difficult-to-make products fuels our targeted growth strategy.

The company has commercial operations in 35 countries with 2,800 employees and operates five manufacturing and development hubs in the U.S., Romania, Korea and Taiwan.

Alvogen's product portfolio consists of a broad range of leading molecules for the treatment of conditions in the areas of oncology, cardiology, respiratory, Women Health, neurology and gastroenterology, in addition to a fast-growing portfolio of biosimilars and OTC products.  


Mr Anil Okay
Mr Anil Okay
Vice President Business Development B2B 

APR Applied Pharma Research SA Switzerland

Mrs Sara Mazzuoccolo
Head of Alliance & Sales 

Csendes Consulting Switzerland

Dr Ivan Csendes
President 

Debiopharm International SA Switzerland

Dr Fabien Sebille
Director Business Development, Licensing Marketing & Communication 
Dr Fabrice Paradies
Director Industrial Business Develpment & Global Commercial Alliances 

Desma Healthcare Switzerland

Dr M. Cristina Armandola
B&D Manager 

F. Hoffmann-La Roche AG Switzerland

Website:
www.roche.com
Dr Christoph Sarry
Dr Christoph Sarry
Global Alliance Director 

Fair-Med Healthcare AG Switzerland

Mr Oren Weininger
CEO 
Dr Oren Weininger
CEO 

Galderma Switzerland

Dr Nicolas Rachinel
Licensing Project Manager 
Dr Johannes Voegel
Head of External Early-Stage Opportunities